Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?

Many patients with coronavirus disease 2019 (COVID-19) have a hyperactive immune response (cytokine storm) which has been incriminated in multiorgan dysfunction (MOD). Interleukin-6 (IL-6) and granulocyte-macrophage colony-stimulating factor (GM-CSF) are the key cytokines involved in mediating syste...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cureus
Main Authors: Mughal, Mohsin S, Kaur, Ikwinder, Kakadia, Mili, Wang, Chang, Alhashemi, Reem, Salloum, Rafah, Ricca, Anthony, Granet, Kenneth
Formato: Artigo
Idioma:Inglês
Publicado em: Cureus 2020
Assuntos:
Internal Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7815303/
https://ncbi.nlm.nih.gov/pubmed/33489621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.12214
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados